@article{fdi:010065666,
  title = {{M}alaria vaccine development in {E}urope-preparing for the future : {W}orkshop report},
  author = {{V}iebig, {N}. {K}. and {D}'{A}lessio, {F}. and {D}raper, {S}. {J}. and {S}im, {B}. {K}. {L}. and {M}ordmuller, {B}. and {B}owyer, {P}. {W}. and {L}uty, {A}drian and {J}ungbluth, {S}. and {C}hitnis, {C}. {E}. and {H}ill, {A}. {V}. {S}. and {K}remsner, {P}. and {C}raig, {A}. {G}. and {K}ocken, {C}. {H}. {M}. and {L}eroy, {O}.},
  editor = {},
  language = {{ENG}},
  abstract = {{T}he deployment of a safe and effective malaria vaccine will be an important tool for the control of malaria and the reduction in malaria deaths. {W}ith the launch of the 2030 {M}alaria {V}accine {T}echnology {R}oadmap, the malaria community has updated the goals and priorities for the development of such a vaccine and is now paving the way for a second phase of malaria vaccine development. {D}uring a workshop in {B}russels in {N}ovember 2014, hosted by the {E}uropean {V}accine {I}nitiative, key players from the {E}uropean, {N}orth {A}merican and {A}frican malaria vaccine community discussed {E}uropean strategies for future malaria vaccine development in the global context. {T}he recommendations of the {E}uropean malaria community should guide researchers, policy makers and funders of global health research and development in fulfilling the ambitious goals set in the updated {M}alaria {V}accine {T}echnology {R}oadmap.},
  keywords = {{M}alaria ; {V}accine ; {C}apacity building ; {C}ontrolled human malaria infection ; {A}ntigen discovery ; {C}orrelates of protection ; {AFRIQUE} ; {EUROPE}},
  booktitle = {},
  journal = {{V}accine},
  volume = {33},
  numero = {46},
  pages = {6137--6144},
  ISSN = {0264-410{X}},
  year = {2015},
  DOI = {10.1016/j.vaccine.2015.09.074},
  URL = {https://www.documentation.ird.fr/hor/fdi:010065666},
}